Pfizer Ventures

Pfizer Ventures is Pfizer's strategic corporate venture capital arm, investing globally in biopharmaceutical companies across five core areas: oncology, inflammation and immunology, cardiovascular, metabolic and obesity, and vaccines, plus platform technology companies. Its page says it invests from seed through IPO with typical initial investments of $5 to 20 million, emphasises early-stage opportunities and follows on in later rounds, and sits within Pfizer's Worldwide Business Development group. The portfolio page lists oncology companies including Artios Pharma ('a leading DNA Damage Response company'), Crossbow Therapeutics (T-cell receptor-mimetic antibodies), Curve Therapeutics (cyclic peptides), Incendia Therapeutics (tumour microenvironment), Kestrel Therapeutics (pan-KRAS), Normunity, Palleon Pharma (glycoimmune checkpoint inhibitors) and Strata Oncology (precision oncology testing).